Diagnosis of Tuberculosis in Swiss Children
Launched by UNIVERSITY CHILDREN'S HOSPITAL BASEL · Feb 3, 2017
Trial Information
Current as of August 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Diagnosis of Tuberculosis in Swiss Children," is focused on improving how we detect tuberculosis (TB) in children. Researchers are testing new tests that can help identify TB disease more accurately. They are also looking for specific markers that can help distinguish between children who have been exposed to TB and those who actually have the disease.
The trial is open to all children and adolescents under 18 years old who are being checked for TB exposure or infection. However, children who are already receiving treatment for TB or who have been treated in the past cannot participate. If eligible, participants can expect to undergo some tests to help researchers understand how to improve TB diagnosis in young people. This study is currently recruiting participants, so there is an opportunity to contribute to better TB detection methods for children in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all children / adolescents \< 18 years of age undergoing evaluation for TB exposure, infection or disease.
- Exclusion Criteria:
- • children / adolescents with TB infection or disease who have already been started on anti-mycobacterial treatment, children who have been treated for TB previously.
About University Children's Hospital Basel
The University Children's Hospital Basel is a leading pediatric healthcare institution committed to advancing child health through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital focuses on developing and evaluating new therapies and interventions tailored to the unique needs of children. With a multidisciplinary team of experienced pediatricians, researchers, and healthcare professionals, the hospital fosters a collaborative environment that prioritizes patient safety and ethical standards. By engaging in cutting-edge clinical trials, the University Children's Hospital Basel aims to enhance treatment options and improve outcomes for pediatric patients, contributing to the broader field of child health and medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarau, , Switzerland
Bern, , Switzerland
Basel, , Switzerland
Bellinzona, , Switzerland
Genève, , Switzerland
Luzern, , Switzerland
St. Gallen, , Switzerland
Zürich, , Switzerland
Basel, , Switzerland
Patients applied
Trial Officials
Nicole Ritz, Prof Dr med
Principal Investigator
UKBB
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials